Yin H - Search Results

1

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.

Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, Choi YJ, Sweeney KE, Suski JM, Yin H, Bogorad RL, Goel S, Yuzugullu H, Kauffman KJ, Yang J, Jin C, Li Y, Floris D, Swanson R, Ng K, Sicinska E, Anders L, Zhao JJ, Polyak K, Anderson DG, Li C, Sicinski P. Hydbring P, et al. Among authors: yin h. Cancer Cell. 2017 Apr 10;31(4):576-590.e8. doi: 10.1016/j.ccell.2017.03.004. Cancer Cell. 2017. PMID: 28399412 Free PMC article.

2

Identification of cell cycle-targeting microRNAs through genome-wide screens.

Hydbring P, Wang Y, Bogorad RL, Yin H, Anderson DG, Li C, Sicinski P. Hydbring P, et al. Among authors: yin h. Cell Cycle. 2017;16(23):2241-2248. doi: 10.1080/15384101.2017.1380132. Epub 2017 Nov 14. Cell Cycle. 2017. PMID: 29099267 Free PMC article.

3

Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice.

Bogorad RL, Yin H, Zeigerer A, Nonaka H, Ruda VM, Zerial M, Anderson DG, Koteliansky V. Bogorad RL, et al. Among authors: yin h. Nat Commun. 2014 May 21;5:3869. doi: 10.1038/ncomms4869. Nat Commun. 2014. PMID: 24844798 Free PMC article.

4

Delivery technologies for genome editing.

Yin H, Kauffman KJ, Anderson DG. Yin H, et al. Nat Rev Drug Discov. 2017 Jun;16(6):387-399. doi: 10.1038/nrd.2016.280. Epub 2017 Mar 24. Nat Rev Drug Discov. 2017. PMID: 28337020 Review.

5

CRISPR-Cas: a tool for cancer research and therapeutics.

Yin H, Xue W, Anderson DG. Yin H, et al. Nat Rev Clin Oncol. 2019 May;16(5):281-295. doi: 10.1038/s41571-019-0166-8. Nat Rev Clin Oncol. 2019. PMID: 30664678 Review.

6

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A, Gupta A, Bolukbasi MF, Walsh S, Bogorad RL, Gao G, Weng Z, Dong Y, Koteliansky V, Wolfe SA, Langer R, Xue W, Anderson DG. Yin H, et al. Nat Biotechnol. 2016 Mar;34(3):328-33. doi: 10.1038/nbt.3471. Epub 2016 Feb 1. Nat Biotechnol. 2016. PMID: 26829318 Free PMC article.

7

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG. Yin H, et al. Nat Biotechnol. 2014 Jun;32(6):551-3. doi: 10.1038/nbt.2884. Epub 2014 Mar 30. Nat Biotechnol. 2014. PMID: 24681508 Free PMC article.

8

RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.

Yin H, Bogorad RL, Barnes C, Walsh S, Zhuang I, Nonaka H, Ruda V, Kuchimanchi S, Nechev L, Akinc A, Xue W, Zerial M, Langer R, Anderson DG, Koteliansky V. Yin H, et al. J Hepatol. 2016 Apr;64(4):899-907. doi: 10.1016/j.jhep.2015.11.028. Epub 2015 Nov 30. J Hepatol. 2016. PMID: 26658687 Free PMC article.

9

Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo.

Khan OF, Zaia EW, Yin H, Bogorad RL, Pelet JM, Webber MJ, Zhuang I, Dahlman JE, Langer R, Anderson DG. Khan OF, et al. Among authors: yin h. Angew Chem Int Ed Engl. 2014 Dec 22;53(52):14397-401. doi: 10.1002/anie.201408221. Epub 2014 Oct 29. Angew Chem Int Ed Engl. 2014. PMID: 25354018 Free PMC article.

10

Precision cancer mouse models through genome editing with CRISPR-Cas9.

Mou H, Kennedy Z, Anderson DG, Yin H, Xue W. Mou H, et al. Among authors: yin h. Genome Med. 2015 Jun 9;7(1):53. doi: 10.1186/s13073-015-0178-7. eCollection 2015. Genome Med. 2015. PMID: 26060510 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,767 results

Search Page

Filters